UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reconsidering the Timing of Aortic Valve Replacement in Symptomatic Normal-Flow Low-Gradient Severe Aortic Stenosis

Korean Circulation Journal, 2023, 53(11), , pp.756-757

Lee, Hsin-Fu

2023

Volltextzugriff (PDF)

Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation

Journal of the American College of Cardiology, 2016-09, Vol.68 (13), p.1389-1401

2016

Volltextzugriff (PDF)

Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation

Journal of the American Heart Association, 2018-04, Vol.7 (8), p.n/a

2018

Volltextzugriff (PDF)

Postoperative Stroke After Type A Aortic Dissection Repair: Hemorrhage Versus Ischemia

World journal of surgery, 2022-03, Vol.46 (3), p.690-700

2022

Volltextzugriff (PDF)

Balloon-expandable versus self-expanding transcatheter aortic valve replacement for bioprosthetic dysfunction: A systematic review and meta-analysis

PloS one, 2020-06, Vol.15 (6), p.e0233894-e0233894

2020

Volltextzugriff (PDF)

Analysis of outcomes and prognostic factor in acute type A aortic dissection complicated with preoperative shock: A single-center study

PloS one, 2024-04, Vol.19 (4), p.e0302669-e0302669

2024

Volltextzugriff (PDF)

The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort study

Cardiovascular diabetology, 2022-06, Vol.21 (1), p.1-118, Article 118

2022

Volltextzugriff (PDF)

A Sequential Route to Cyclopentenes from 1,6‐Enynes and Diazo Ketones through Gold and Rhodium Catalysis

Advanced synthesis & catalysis, 2017-02, Vol.359 (3), p.402-409

2017

Volltextzugriff (PDF)

Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation

Journal of the American Heart Association, 2019-03, Vol.8 (5), p.e011112

2019

Volltextzugriff (PDF)

Comparing clinical outcomes in patients with type 2 diabetes mellitus after ischaemic stroke: Sodium–glucose cotransporter 2 inhibitors users versus non‐users. A propensity score matching National Cohort Study

Diabetes, obesity & metabolism, 2024-10, Vol.26 (10), p.4501-4509

2024

Volltextzugriff (PDF)

Clinical Outcomes in Type 2 Diabetes Patients After Acute Myocardial Infarction: A Comparison of Sodium–Glucose Cotransporter 2 Inhibitors vs. Non‐Users

Clinical pharmacology and therapeutics, 2024-08, Vol.116 (2), p.426-434

2024

Volltextzugriff (PDF)

Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin

Journal of the American College of Cardiology, 2016-11, Vol.68 (21), p.2272-2283

2016

Volltextzugriff (PDF)

Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase-4 inhibitor

Cardiovascular diabetology, 2020-09, Vol.19 (1), p.160-160, Article 160

2020

Volltextzugriff (PDF)

Acute type a aortic intramural hematoma complicated with preoperative hemopericardium: early and late surgical outcome analyses

Journal of cardiothoracic surgery, 2024-03, Vol.19 (1), p.123-123, Article 123

2024

Volltextzugriff (PDF)

Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants

Cardiovascular diabetology, 2020-05, Vol.19 (1), p.63-63, Article 63

2020

Volltextzugriff (PDF)

Delayed sternal closure for intractable bleeding after acute type A aortic dissection repair: outcomes and risk factors analyses

Journal of cardiothoracic surgery, 2022-08, Vol.17 (1), p.1-184, Article 184

2022

Volltextzugriff (PDF)

High Nighttime Heart Rate is Associated with Increased Risk of All-Cause Mortality in Patients with Heart Failure and Reduced Ejection Fraction

International Heart Journal, 2020/03/28, Vol.61(2), pp.289-294

2020

Volltextzugriff (PDF)

Impacts of Different Renal Function Estimation Formulas on Dosing of DOACs and Clinical Outcomes

Journal of the American College of Cardiology, 2020-10, Vol.76 (15), p.1808-1810

2020

Volltextzugriff (PDF)

Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis

Cardiovascular drugs and therapy, 2021-10, Vol.35 (5), p.975-986

2021

Volltextzugriff (PDF)

Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation

Cardiovascular diabetology, 2020-03, Vol.19 (1), p.30-30, Article 30

2020

Volltextzugriff (PDF)

Direct Oral Anticoagulants in Atrial Fibrillation Patients With Concomitant Hyperthyroidism

The journal of clinical endocrinology and metabolism, 2020-09, Vol.105 (9), p.2893-2904

2020

Volltextzugriff (PDF)

Comparisons of Rivaroxaban Following Different Dosage Criteria (ROCKET AF or J-ROCKET AF Trials) in Asian Patients With Atrial Fibrillation

Journal of the American Heart Association, 2019-11, Vol.8 (21), p.e013053

2019

Volltextzugriff (PDF)

Young Male Patients with Atrial Fibrillation and CHA2DS2-VASc Score of 1 May Not Need Anticoagulants: A Nationwide Population-Based Study

PloS one, 2016-03, Vol.11 (3), p.e0151485-e0151485

2016

Volltextzugriff (PDF)

Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan

Cardiovascular diabetology, 2017-12, Vol.16 (1), p.159-159, Article 159

2017

Volltextzugriff (PDF)

Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis

Cardiovascular drugs and therapy, 2019-12, Vol.33 (6), p.701-710

2019

Volltextzugriff (PDF)

1 – 25 von 220

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(184)
Mit Volltextzugriff
(197)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Reconsidering the Timing of Aortic Valve Replacement in Symptomatic Normal-Flow Low-Gradient Severe Aortic Stenosis

Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation

Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation

Postoperative Stroke After Type A Aortic Dissection Repair: Hemorrhage Versus Ischemia

Balloon-expandable versus self-expanding transcatheter aortic valve replacement for bioprosthetic dysfunction: A systematic review and meta-analysis

Analysis of outcomes and prognostic factor in acute type A aortic dissection complicated with preoperative shock: A single-center study

The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort study

A Sequential Route to Cyclopentenes from 1,6‐Enynes and Diazo Ketones through Gold and Rhodium Catalysis

Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation

Comparing clinical outcomes in patients with type 2 diabetes mellitus after ischaemic stroke: Sodium–glucose cotransporter 2 inhibitors users versus non‐users. A propensity score matching National Cohort Study

Clinical Outcomes in Type 2 Diabetes Patients After Acute Myocardial Infarction: A Comparison of Sodium–Glucose Cotransporter 2 Inhibitors vs. Non‐Users

Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin

Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase-4 inhibitor

Acute type a aortic intramural hematoma complicated with preoperative hemopericardium: early and late surgical outcome analyses

Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants

Delayed sternal closure for intractable bleeding after acute type A aortic dissection repair: outcomes and risk factors analyses

High Nighttime Heart Rate is Associated with Increased Risk of All-Cause Mortality in Patients with Heart Failure and Reduced Ejection Fraction

Impacts of Different Renal Function Estimation Formulas on Dosing of DOACs and Clinical Outcomes

Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis

Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation

Direct Oral Anticoagulants in Atrial Fibrillation Patients With Concomitant Hyperthyroidism

Comparisons of Rivaroxaban Following Different Dosage Criteria (ROCKET AF or J-ROCKET AF Trials) in Asian Patients With Atrial Fibrillation

Young Male Patients with Atrial Fibrillation and CHA2DS2-VASc Score of 1 May Not Need Anticoagulants: A Nationwide Population-Based Study

Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan

Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis

Suchergebnisse filtern